http://www.ambergen.com/wp-content/uploads/logo-retina.png 0 0 Kenneth Rothschild http://www.ambergen.com/wp-content/uploads/logo-retina.png Kenneth Rothschild2012-04-27 13:45:012016-11-10 12:44:59AmberGen receives US Patent 8,148,062 for detecting disease causing genetic mutations such as breast and colorectal cancer using affinity tags in translated nascent proteins
Get in Touch
313 Pleasant St.
Watertown, MA 02472
- Dr. Gargey Yagnik joins AmberGen as Program Coordinator for Mass Spectrometry. In his previous position as a postdoctoral researcher at Sanofi Genzyme he developed new methods for MALDI-MSI tissue imaging. He received his Ph.D. from Iowa State University in analytical chemistry. January 2017
- AmberGen awarded two US Patents (9,334,530 and 9,523,680) providing broad coverage for its Bead-AMS™ technology December 2016